ArticleOncoTargets and therapy2020

Association of TP53 Mutations with Response to Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer.

Shencun Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.